Literature DB >> 16832102

Early progressive encephalopathy in boys and MECP2 mutations.

P Kankirawatana1, H Leonard, C Ellaway, J Scurlock, A Mansour, C M Makris, L S Dure, M Friez, J Lane, C Kiraly-Borri, V Fabian, M Davis, J Jackson, J Christodoulou, W E Kaufmann, D Ravine, A K Percy.   

Abstract

MECP2 mutations mainly occur in females with Rett syndrome. Mutations have been described in 11 boys with progressive encephalopathy: seven of nine with affected sisters and two de novo. The authors report four de novo occurrences: three pathogenic and one potentially pathogenic. Common features include failure to thrive, respiratory insufficiency, microcephaly, and abnormal motor control. MECP2 mutations should be assessed in boys with progressive encephalopathy and one or more of respiratory insufficiency, abnormal movements or tone, and intractable seizures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16832102     DOI: 10.1212/01.wnl.0000223318.28938.45

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

1.  MeCP2 is critical within HoxB1-derived tissues of mice for normal lifespan.

Authors:  Christopher S Ward; E Melissa Arvide; Teng-Wei Huang; Jong Yoo; Jeffrey L Noebels; Jeffrey L Neul
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

2.  Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations.

Authors:  Christopher A Chapleau; Gaston D Calfa; Meredith C Lane; Asher J Albertson; Jennifer L Larimore; Shinichi Kudo; Dawna L Armstrong; Alan K Percy; Lucas Pozzo-Miller
Journal:  Neurobiol Dis       Date:  2009-05-12       Impact factor: 5.996

3.  The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2.

Authors:  Jeffrey L Neul; Timothy A Benke; Eric D Marsh; Steven A Skinner; Jonathan Merritt; David N Lieberman; Shannon Standridge; Timothy Feyma; Peter Heydemann; Sarika Peters; Robin Ryther; Mary Jones; Bernhard Suter; Walter E Kaufmann; Daniel G Glaze; Alan K Percy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-12-07       Impact factor: 3.568

4.  A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations.

Authors:  Alexander H Joyner; Cooper Roddey J; Cinnamon S Bloss; Trygve E Bakken; Lars M Rimol; Ingrid Melle; Ingrid Agartz; Srdjan Djurovic; Eric J Topol; Nicholas J Schork; Ole A Andreassen; Anders M Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

5.  The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.

Authors:  Stephanie Fehr; Meredith Wilson; Jenny Downs; Simon Williams; Alessandra Murgia; Stefano Sartori; Marilena Vecchi; Gladys Ho; Roberta Polli; Stavroula Psoni; Xinhua Bao; Nick de Klerk; Helen Leonard; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2012-08-08       Impact factor: 4.246

Review 6.  Rett syndrome: exploring the autism link.

Authors:  Alan K Percy
Journal:  Arch Neurol       Date:  2011-08

Review 7.  Experimental models of Rett syndrome based on Mecp2 dysfunction.

Authors:  Gaston Calfa; Alan K Percy; Lucas Pozzo-Miller
Journal:  Exp Biol Med (Maywood)       Date:  2011-01

8.  Progressive Changes in a Distributed Neural Circuit Underlie Breathing Abnormalities in Mice Lacking MeCP2.

Authors:  Teng-Wei Huang; Mikhail Y Kochukov; Christopher S Ward; Jonathan Merritt; Kaitlin Thomas; Tiffani Nguyen; Benjamin R Arenkiel; Jeffrey L Neul
Journal:  J Neurosci       Date:  2016-05-18       Impact factor: 6.167

9.  Variable phenotypic expression of a MECP2 mutation in a family.

Authors:  Kimberly Augenstein; Jane B Lane; Antony Horton; Carolyn Schanen; Alan K Percy
Journal:  J Neurodev Disord       Date:  2009-12       Impact factor: 4.025

10.  Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus.

Authors:  Shay Ben-Shachar; Maria Chahrour; Christina Thaller; Chad A Shaw; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.